The DIP Symposium continuously aims to lead a greater global focus on Hypertension in Pregnancy (HIP), maternal and fetal medicine. Doing so by raising awareness of the links between hyperglycemia and poor maternal and fetal outcomes as well as to the future health risks to mother and offspring and demand a clearly defined global health agenda to tackle this issue. To provide guidance for testing, management and care of women with HIP regardless of resource setting as outlined in the FIGO document and to inspire action by showcasing ongoing initiatives on diabetes in pregnancy in the region and globally.
The DIPAP Greater China Symposium will introduce a unique program on “Digital Health” whereby start-up companies, innovative concepts, development of ideas to execution will be brought to the forefront in keynote lectures and demonstrations. A never-before collaboration of Scientific content and hi-tech will meet, listen and discuss on the third day of the Symposium. The Digital Health program will successfully address and highlight the importance of introducing and including digital health within the treatment of Diabetes, Hypertension, Metabolic Syndrome and Pregnancy.